Galmed Pharma Data Demonstrates Significant Reduction of Inflammation

Thursday, March 31, 2016

Galmed Pharmaceuticals Pre-Clinical data demonstrating significant anti-fibrotic activity of Aramchol in Methionine and choline deficient diet in mice.

Studies showed both statistically significant reduction of inflammation and statically significant effect on liver fibrosis.

 

Source : reuters.com